Back to Agenda
SESSION 4: Sample Management
Session Chair(s)
Neveen Kamel
Regulatory Affairs Head North Africa, Egypt & French-speaking Africa, Merck Group, Egypt
Zainab Aziz, MSC, RPH
Associate Director- Regulatory Policy MEA, Novartis, South Africa
Overview: This session will explore challenges associated with sample provision for Post-Approval Changes and promote best practices in Sample Management, leveraging Reliance pathways. The session will also highlight the development of a unified laboratory framework for sample testing through the Network of African Reliance Laboratories (NARL), the growing importance of post-marketing surveillance, share effective risk management strategies for product release post-importation and emphasise capacity building for local laboratories to detect substandard and falsified medicines.
Speaker(s)
Zainab Aziz, MSC, RPH
Associate Director- Regulatory Policy MEA, Novartis, South Africa
Joerg Garbe, PHD, MSC
IFPMA In-Country Testing Taskforce Lead; Global Quality Manager & Policy Lead, F. Hoffmann-La Roche Ltd, Switzerland
Neven Ahmed
Reliance team leader, Egyptian Drug Authority (EDA), Egypt
Noha Mohamed Reda Arram
Head of Drug Quality Control Laboratory - Pharmacy & Drug Control Department, Ministry of Public Health (MOPH), Qatar, Qatar
Assane Coulibaly
CEO / Director General, Autorité Ivoirienne de Régulation Pharmaceutique (AIRP) / Ivorian Pharm RA, Côte d'Ivoire
Have an account?